Prostate cancer is the second-most common cancer in men. A new study from Thomas Jefferson University uncovered a new ...
Prostate cancer that has spread to other parts of the body has limited treatment options, but a biomedical research group affiliated with Main Line Health has begun investigating a new therapy for ...
Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) were recently ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in bone tissue, offering a potential new treatment target for patients with ...
In men with newly diagnosed metastatic hormone-sensitive prostate cancer, adding lutetium-177 PSMA-617 (177 Lu-PSMA-617) to standard hormone therapy led to a statistically significant improvement in ...
After being described in 2018, researchers knew they had something interesting with T3p, a single small RNA found in breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results